University of Texas Southwestern, Simmons Comprehensive Cancer Center (104) is a clinical research site located in Dallas, Texas, United States 75390.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
University of Texas Southwestern, Simmons Comprehensive Cancer Center (104) has participated in 1 clinical trials.
Therapeutic areas: AML With Monocytic Differentiation, CMML.
Sponsors: Immune-Onc Therapeutics.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Texas Southwestern, Simmons Comprehensive Cancer Center (104) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Texas Southwestern, Simmons Comprehensive Cancer Center (104) has 1 clinical trials on record. Their work covers AML With Monocytic Differentiation, CMML.
University of Texas Southwestern, Simmons Comprehensive Cancer Center (104) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.